Keyphrases
Active Compounds
45%
AIDS/HIV
16%
Antibiotic Residues
16%
Antibiotic Resistance
10%
Antigenic Variation
8%
Antimicrobial
26%
Antiretroviral Therapy
24%
Apium Graveolens
8%
Apoptosis
33%
Apoptosis-inducing Factor
16%
Apoptotic Cells
16%
Artocarpin
8%
B-cell Lymphoma 2 (Bcl-2)
14%
Bacterial Contamination
16%
Bacterial Infection
9%
Beef Meat
19%
Bone Fracture Healing
8%
Broiler
8%
Camellia Sinensis
17%
Caspase-12
8%
Caspase-3
11%
CD206
8%
CD4+
12%
Celery
8%
Celery Extract
8%
Cell Proliferation
9%
Cell Pyroptosis
8%
Cisplatin
33%
Coliform Bacteria
19%
CRF01_AE
22%
Cynomolgus Macaque
9%
Cynomolgus Monkey
8%
DNA Recombination
8%
Drug Resistance mutations
16%
East Java Province
19%
Epigallocatechin-3-gallate
16%
Escherichia Coli
20%
Ethanol Extract
16%
Ethyl Acetate
11%
Evolutionary Change
8%
Ficus Fistulosa
16%
Glomerular Epithelial Cells
8%
Glomerular Parietal Epithelial Cell
8%
Glutamine
33%
Green Tea
37%
Hajj
8%
Halal Slaughter
8%
HIV Patients
10%
Human Immune System
8%
Human Immunodeficiency Virus Type 1 (HIV-1)
33%
IFN Response
8%
Immune Response
9%
Inactivated SARS-CoV-2 Vaccine
25%
Incision Wound
9%
Indonesia
100%
Indonesian
25%
Infected Individual
18%
Leaf Extract
8%
M2 Microglia
8%
Macaca Fascicularis
9%
Male Rats
9%
Microbial Contamination
10%
Microglial Markers
8%
Middle Cerebral Artery Occlusion Model
18%
Mycoplasma
8%
Mycoplasma Genitalium
8%
Mycoplasma Pneumoniae (M. pneumoniae)
8%
N-hexane
9%
Necroptosis
9%
Neuronal Apoptosis
8%
Newly Diagnosed
10%
No Significant Difference
9%
Patients with Diabetes Mellitus
10%
Phage Therapy
8%
Phage-bacteria
8%
Phaleria Macrocarpa
8%
Podocyte
8%
Positive Samples
10%
Postpartum Infection
8%
Potential Vaccine Candidate
8%
Pumpkin Seed
8%
Rattus Norvegicus
24%
Risk Factors
11%
Slaughterhouse
16%
Staphylococcus Aureus
14%
Staphylococcus Epidermidis (S. epidermidis)
12%
Staphylococcus Spp
16%
Surabaya
25%
Total Plate Count
19%
Transient Middle Cerebral Artery Occlusion (tMCAO)
9%
Transmitted Drug Resistance
9%
Treatment Group
16%
Tuberculosis
14%
Type 1 Diabetes Mellitus (T1DM)
16%
Ulcer Disease
8%
Urinary Tract Infection
16%
Vaccine Candidate
25%
Wistar
9%
Wound Healing
15%
Zone of Inhibition
15%
Pharmacology, Toxicology and Pharmaceutical Science
Acetic Acid Ethyl Ester
12%
Acute Hepatitis B
8%
Adverse Event
6%
Aeromonas hydrophila
8%
Andrographis paniculata
8%
Anti-Human Immunodeficiency Virus
11%
Anti-Inflammatory Drug
13%
Antibiotics
7%
Antiinfective Agent
20%
Antiinflammatory Activity
8%
Antimicrobial Agent
19%
Antimicrobial Resistance
8%
Apoptosis Inducing Factor
8%
Apoptotic Protease Activating Factor 1
8%
Bacterial Infection
8%
Bone Defect
8%
Brain Injury
8%
Breast Cancer
8%
Calcium Lactate
8%
Caspase 12
8%
Caspase 3
15%
CD8 Antigen
6%
Cecropin
5%
Celery
8%
Cerebral Palsy
8%
Cerebrovascular Accident
10%
Chronic Hepatitis B
8%
Cisplatin
25%
Clinical Trial
8%
Coliform Bacterium
8%
COVID-19 Vaccine
8%
Cross-Sectional Study
8%
Cytokine
9%
Diabetes Mellitus
25%
Dimethylbenz[a]anthracene
8%
Diseases
18%
Drug Resistance
18%
Enzyme-Linked Immunosorbent Assay
11%
Epidermal Growth Factor
8%
Epigallocatechin Gallate
8%
Escherichia coli
7%
Ficus
16%
Fracture Healing
8%
Gallic Acid
8%
Glutamine
25%
Gram Negative Bacterium
8%
Helminthiasis
8%
Hepatitis B Virus
8%
Hepatitis C
8%
Hexane
10%
HIV
25%
Human Immunodeficiency Virus 1
8%
Hydroxyapatite
8%
Hyperplasia
8%
IC50
7%
Implant
6%
In Vitro Screening
8%
Infectious Agent
8%
Inflammation
17%
Interleukin 10
5%
Interleukin 4
5%
Maggot
8%
Malignant Neoplasm
9%
Methanol
10%
Middle Cerebral Artery Occlusion
16%
Mouse Model
8%
Neutralizing Antibody
8%
Outer Membrane Protein
8%
Penicillin
8%
Pharmacotherapy
8%
Physalis
8%
Plant Extract
6%
Prevalence
32%
Protein M2
8%
Protein P53
11%
Rat Model
8%
Rattus norvegicus
23%
Side Effect
5%
Sinecatechins
10%
Spinal Cord Injury
8%
Telomerase
6%
Transcription Factor GATA 3
8%
Treatment Group
24%
Tumor Necrosis Factor
5%
Ulcer
8%
Urinary Tract Infection
16%
Vascular Disease
8%
Western Blot
5%
Wound
10%
Wound Healing
16%